Drug:
Reaction: PARAESTHESIA
20250101 - 20251231
No. 3301 - 3400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 3301 | 25161535 |
15 | 2 | |
Paraesthesia, Pain, |
||||
PYRIDOSTIGMINE BROMIDE ORAL, BACLOFEN, |
||||
| 3302 | 25147470 |
US |
84 | 2 |
Dehydration, Decreased appetite, Diarrhoea, Sinusitis, Paraesthesia, Muscle spasms, Vomiting, Blood calcium decreased, Pain in extremity, |
||||
DENOSUMAB, ERGOCALCIFEROL, MAGNESIUM, |
||||
| 3303 | 25147786 |
FI |
74 | 2 |
Seizure, Tremor, Joint effusion, Allergic reaction to excipient, Exposure via partner, Chills, Hypoaesthesia, Exposure via inhalation, Skin burning sensation, Discomfort, Anxiety, Blood pressure increased, Dyspnoea, Arthralgia, Nausea, Paraesthesia, Myalgia, Accidental exposure to product, Product complaint, Product formulation issue, Product substitution issue, |
||||
EZETIMIBE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CEPHALEXIN, TRIMETHOPRIM, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, BISOPROLOL FUMARATE, AMLODIPINE, ROSUVASTATIN CALCIUM, LEVOTHYROXINE, |
||||
| 3304 | 25147931 |
CA |
33 | 2 |
Suspected product tampering, Attention deficit hyperactivity disorder, Condition aggravated, Drug ineffective, Pain, Peripheral swelling, Photosensitivity reaction, Withdrawal syndrome, Rash, Abdominal pain, Cognitive disorder, Alopecia, Swelling, Temperature regulation disorder, Gastrointestinal pain, Urinary tract pain, Headache, Paraesthesia, Brain fog, Haemorrhage, Vaginal disorder, Anorectal disorder, Tremor, Chills, Hyperhidrosis, Arthralgia, Rash erythematous, Burning sensation, Dysphagia, Hepatic pain, Breast pain, Dyspepsia, Product dosage form issue, Product physical issue, Product taste abnormal, Product size issue, Product formulation issue, Product shape issue, Joint swelling, Anxiety, Dyspnoea, Therapy interrupted, Product availability issue, Product substitution issue, Drug interaction, Product colour issue, Product physical consistency issue, |
||||
LISDEXAMFETAMINE DIMESYLATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, NIRMATRELVIR AND RITONAVIR, ERGOCALCIFEROL, FAMOTIDINE, |
||||
| 3305 | 25148189 |
CA |
59 | 2 |
Dyspnoea, Pulmonary embolism, Influenza, Fall, Forced expiratory volume decreased, Insomnia, Diarrhoea, Oxygen saturation decreased, Depression, Fluid retention, Anxiety, Condition aggravated, Blood pressure increased, Middle insomnia, Cough, Wheezing, Paraesthesia, Concomitant disease aggravated, Weight decreased, Pulmonary congestion, Cardiac murmur, Weight increased, Therapeutic product effect decreased, Asthma, Vomiting, Pneumonia, Vital capacity decreased, Deep vein thrombosis, Restlessness, |
||||
BISOPROLOL FUMARATE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, IRBESARTAN, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREDNISONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, MONTELUKAST SODIUM, THEOPHYLLINE, SERTRALINE HYDROCHLORIDE, ALBUTEROL SULFATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FUROSEMIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, MELATONIN, LEVOTHYROXINE SODIUM, |
||||
| 3306 | 25148257 |
DK |
||
Disseminated tuberculosis, False negative investigation result, Drug-induced liver injury, Tuberculosis, Atypical pneumonia, Normochromic normocytic anaemia, Paraesthesia, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METHOTREXATE, METHOTREXATE SODIUM, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, LINEZOLID, CYCLOSERINE, CLARITHROMYCIN, SULFASALAZINE, METHOTREXATE SODIUM, |
||||
| 3307 | 25148413 |
CA |
46 | 2 |
Infusion related reaction, Paraesthesia, Dry skin, Skin tightness, Chills, Condition aggravated, Rash, Facial pain, Feeling hot, Product substitution issue, Abdominal pain lower, Diarrhoea, Pruritus, Skin irritation, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, TELMISARTAN, |
||||
| 3308 | 25148528 |
US |
44 | 2 |
Musculoskeletal disorder, Paraesthesia, Hypoaesthesia, Somnolence, Psoriasis, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 3309 | 25149273 |
ES |
54 | 2 |
Paraesthesia, Dizziness, |
||||
SERTRALINE, |
||||
| 3310 | 25150129 |
US |
2 | |
Paraesthesia, Dysuria, |
||||
PONESIMOD, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 3311 | 25150495 |
US |
58 | 1 |
Gait inability, Impaired driving ability, Oral mucosal blistering, Paraesthesia, Abdominal pain upper, Stomatitis, Pain in extremity, Pain, Peripheral swelling, Erythema, Skin erosion, Blister, Oral mucosal roughening, |
||||
REGORAFENIB, REGORAFENIB, REGORAFENIB, REGORAFENIB, REGORAFENIB, |
||||
| 3312 | 25150803 |
US |
77 | 1 |
Neuropathy peripheral, Haematochezia, Productive cough, Secretion discharge, Dyspnoea, Asthenia, Respiratory tract infection, Paraesthesia, Myalgia, Eye pruritus, Condition aggravated, Injection site pain, Exposure via skin contact, Accidental exposure to product, |
||||
DUPILUMAB, |
||||
| 3313 | 25150876 |
US |
24 | 2 |
Flushing, Paraesthesia, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3314 | 25151143 |
US |
1 | |
Paraesthesia, Burning sensation, Injection site mass, Blood pressure increased, Condition aggravated, Headache, Dizziness, |
||||
DUPILUMAB, |
||||
| 3315 | 25151180 |
US |
63 | 2 |
Hypoaesthesia, Paraesthesia, |
||||
DIMETHYL FUMARATE, DIMETHYL FUMARATE, DIMETHYL FUMARATE, DIMETHYL FUMARATE, |
||||
| 3316 | 25151720 |
US |
62 | 2 |
Pleural effusion, Decreased immune responsiveness, Pulmonary nocardiosis, Neuropathy peripheral, White blood cell count decreased, Abdominal discomfort, Neutrophil count decreased, Streptococcal infection, COVID-19, Joint swelling, Pigmentation disorder, Arthritis, Paraesthesia, Increased tendency to bruise, Hypoaesthesia, Asthenia, Fatigue, Pain in extremity, Platelet count decreased, Nausea, Back pain, Diarrhoea, Vomiting, |
||||
IXAZOMIB, IXAZOMIB, IXAZOMIB, IXAZOMIB, IXAZOMIB, IXAZOMIB, IXAZOMIB, IXAZOMIB, IXAZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, POMALIDOMIDE, |
||||
| 3317 | 25152177 |
US |
56 | 1 |
Syringomyelia, Therapeutic product effect decreased, Hypertension, Paraesthesia, Erythema, Multiple sclerosis, COVID-19, |
||||
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, |
||||
| 3318 | 25152272 |
CA |
50 | 2 |
Abdominal pain upper, Adverse drug reaction, Adverse event, Anti-cyclic citrullinated peptide antibody positive, Asthenia, C-reactive protein abnormal, Condition aggravated, Contraindicated product administered, Contusion, Diarrhoea, Discomfort, Dyspnoea, Fibromyalgia, Frequent bowel movements, Hand deformity, Hepatic enzyme increased, Hypersensitivity, Infection, Insomnia, Joint range of motion decreased, Joint swelling, Lip dry, Liver disorder, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Lupus-like syndrome, Malaise, Medication error, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Night sweats, Obesity, Oedema, Oedema peripheral, Off label use, Osteoarthritis, Osteoporosis, Pain in extremity, Pancreatitis, Paraesthesia, Peripheral swelling, Peripheral venous disease, Pneumonia, Porphyria acute, Prescribed overdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Rectal haemorrhage, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Weight decreased, Weight fluctuation, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, Abdominal discomfort, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, PREDNISONE, APREPITANT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, SULFASALAZINE, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOGESTREL AND ETHINYL ESTRADIOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, APREPITANT, FOSAPREPITANT DIMEGLUMINE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INDOMETHACIN, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, SECUKINUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, DESOXIMETASONE, ERGOCALCIFEROL, TOFACITINIB, TOFACITINIB, TOFACITINIB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, QUETIAPINE FUMARATE, QUETIAPINE, LORAZEPAM, LANSOPRAZOLE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ERGOCALCIFEROL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DESOGESTREL AND ETHINYL ESTRADIOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 3319 | 25152518 |
FR |
47 | 1 |
Paraesthesia, Dyspnoea, |
||||
AMIVANTAMAB, CARBOPLATIN, PEMETREXED DISODIUM, |
||||
| 3320 | 25152549 |
SK |
43 | 2 |
Neuropathy peripheral, Oedema peripheral, Face oedema, Diarrhoea, Weight decreased, Hypokalaemia, Paraesthesia, Myalgia, Arthralgia, Lacrimation increased, Fluid retention, Headache, Muscle spasms, Periorbital oedema, Generalised oedema, Seizure, Weight increased, |
||||
DASATINIB, DASATINIB, DASATINIB, |
||||
| 3321 | 25152646 |
US |
2 | |
Suicidal ideation, Self-injurious ideation, Product dose omission issue, Extra dose administered, Tremor, Dyskinesia, Musculoskeletal disorder, Motor dysfunction, Headache, Gastrointestinal pain, Gait disturbance, Hypoaesthesia, Speech disorder, Paraesthesia, Anal incontinence, Aphasia, Disturbance in attention, Balance disorder, Arthritis, Depressed mood, Fatigue, Asthenia, Decreased appetite, Psychomotor hyperactivity, Restlessness, Astigmatism, Reading disorder, Dysstasia, Hypersomnia, Flushing, Abdominal pain upper, Diarrhoea, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, CYCLOBENZAPRINE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, GABAPENTIN, GABAPENTIN, PANTOPRAZOLE, BREXPIPRAZOLE, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, |
||||
| 3322 | 25143605 |
US |
||
Peripheral venous disease, Paraesthesia, Burning sensation, Rash, Hot flush, Incorrect dose administered, |
||||
RELUGOLIX, |
||||
| 3323 | 25143781 |
GB |
63 | 2 |
Paraesthesia, Hypoaesthesia, Headache, Malaise, |
||||
EZETIMIBE, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, EMPAGLIFLOZIN, LOSARTAN, TIRZEPATIDE, |
||||
| 3324 | 25143946 |
US |
||
Cerebral vasoconstriction, Transient ischaemic attack, Paraesthesia, Cerebral artery occlusion, |
||||
TADALAFIL, |
||||
| 3325 | 25144066 |
US |
2 | |
Paraesthesia, |
||||
TIRZEPATIDE, |
||||
| 3326 | 25144124 |
US |
||
Erectile dysfunction, Suicidal ideation, Agitation, Anxiety, Cognitive disorder, Depression, Fatigue, Genital disorder, Hypogonadism, Insomnia, Male sexual dysfunction, Panic attack, Penile size reduced, Testicular disorder, Paraesthesia, Urological examination abnormal, Drug ineffective, Product formulation issue, Therapy cessation, |
||||
SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 3327 | 25144257 |
US |
2 | |
Eye oedema, Ocular icterus, Limb discomfort, Paraesthesia, Peripheral swelling, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, |
||||
| 3328 | 25144290 |
NL |
68 | 1 |
Paraesthesia, Feeling hot, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 3329 | 25144321 |
EU |
51 | 2 |
Pyrexia, Malaise, Paraesthesia, Neutrophil count decreased, Hot flush, Rash, Photosensitivity reaction, Diarrhoea, Nausea, Fatigue, Abdominal pain upper, Constipation, Head discomfort, Musculoskeletal discomfort, Sleep disorder, Nausea, Abdominal pain upper, Headache, Night sweats, Nausea, Abdominal pain, Dysgeusia, Paraesthesia, |
||||
RIBOCICLIB, RIBOCICLIB, |
||||
| 3330 | 25144605 |
IT |
||
Crohn^s disease, Lower respiratory tract infection, Psoriatic arthropathy, Therapeutic response changed, Injection site pain, Rash pustular, Drug ineffective, Arthralgia, Psoriasis, Pruritus, Headache, Arthritis, Condition aggravated, Loss of therapeutic response, Product substitution issue, COVID-19, Urticaria, Erythema, Skin exfoliation, Pyrexia, Dizziness, Abdominal pain, Malaise, Asthenia, Dyspnoea, Back pain, Therapy non-responder, Injection site erythema, Paraesthesia, Myalgia, Cough, Vomiting, Anxiety, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 3331 | 25144664 |
CA |
40 | 2 |
Infusion related reaction, Pain, Psoriatic arthropathy, Malaise, Rash, Injection site reaction, Joint swelling, Neck pain, Memory impairment, Pneumonia, Nail disorder, Liver injury, Obesity, Paraesthesia, Insomnia, Lip dry, Night sweats, Pericarditis, Mobility decreased, Irritable bowel syndrome, Stomatitis, Lung disorder, Muscle injury, Osteoarthritis, Nausea, Nasopharyngitis, Onychomadesis, Pemphigus, Rheumatic fever, Rheumatoid arthritis, Abdominal discomfort, Musculoskeletal stiffness, Migraine, Lower respiratory tract infection, Synovitis, Pain in extremity, Muscular weakness, Injury, Muscle spasms, Sleep disorder, Systemic lupus erythematosus, Swelling, Peripheral swelling, Joint range of motion decreased, Onychomycosis, Liver function test increased, |
||||
DICLOFENAC SODIUM, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, NAPROXEN, NAPROXEN SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RANITIDINE, MEPOLIZUMAB, ETANERCEPT, ETANERCEPT, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, MINOCYCLINE HYDROCHLORIDE, AZATHIOPRINE SODIUM, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ERGOCALCIFEROL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, GOLIMUMAB, HYDROXYCHLOROQUINE, USTEKINUMAB, BOTULINUM TOXIN TYPE A, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, GOLIMUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 3332 | 25145528 |
US |
59 | 1 |
Paraesthesia, Hypoaesthesia, Insomnia, |
||||
SARILUMAB, GABAPENTIN, PREDNISONE, |
||||
| 3333 | 25145688 |
US |
21 | 2 |
Hypersensitivity, Feeling hot, Hyperhidrosis, Tetany, Anxiety, Muscle spasms, Hypoaesthesia, Paraesthesia, Blood potassium decreased, |
||||
TRISODIUM CITRATE DIHYDRATE, MAGNESIUM, ERGOCALCIFEROL, FISH OIL, |
||||
| 3334 | 25145926 |
US |
60 | 1 |
Gait inability, Dysarthria, Paraesthesia, Diarrhoea, |
||||
REGORAFENIB, REGORAFENIB, |
||||
| 3335 | 25145949 |
CA |
44 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Colitis ulcerative, Condition aggravated, Confusional state, Contusion, Crohn^s disease, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Ear infection, Exostosis, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Folliculitis, Foot deformity, Frequent bowel movements, Gait disturbance, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Laboratory test abnormal, Laryngitis, Lip dry, Liver disorder, Liver injury, Lower respiratory tract infection, Lung disorder, Lupus vulgaris, Lupus-like syndrome, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pancreatitis, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Porphyria acute, Pruritus, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Rectal haemorrhage, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sinusitis, Sleep disorder due to a general medical condition, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight fluctuation, Weight increased, Wheezing, White blood cell count increased, Wound, Wound infection, X-ray abnormal, Loss of personal independence in daily activities, Maternal exposure during pregnancy, Walking aid user, Off label use, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LORAZEPAM, CAFFEINE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, ERYTHROMYCIN, FLUOROMETHOLONE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYALURONIDASE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LANSOPRAZOLE, LEFLUNOMIDE, LISINOPRIL, LORAZEPAM, PREGABALIN, MAGNESIUM, MELOXICAM, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREGABALIN, LANSOPRAZOLE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, RITUXIMAB, RITUXIMAB, SULFASALAZINE, SULFASALAZINE, ALBUTEROL SULFATE, ALBUTEROL, ASCORBIC ACID, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, LISINOPRIL, SECUKINUMAB, |
||||
| 3336 | 25146134 |
US |
||
Accidental exposure to product, Device delivery system issue, Device leakage, Exposure via skin contact, Injection site pain, Incorrect dose administered by device, Drug delivery system malfunction, Paraesthesia, |
||||
GUSELKUMAB, GUSELKUMAB, |
||||
| 3337 | 25146388 |
US |
||
Bone pain, Paraesthesia, |
||||
AVAPRITINIB, |
||||
| 3338 | 25146497 |
US |
2 | |
Injection site bruising, Injection site pain, Neck pain, Hypoaesthesia, Paraesthesia, Pain in extremity, Muscle spasms, Fatigue, Nasal congestion, Musculoskeletal stiffness, Headache, Sinus disorder, Discomfort, Contusion, Rhinalgia, Trigger finger, Ill-defined disorder, |
||||
EVOLOCUMAB, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, |
||||
| 3339 | 25146736 |
GB |
58 | 2 |
Paraesthesia, Dry skin, Anxiety, Pain in extremity, |
||||
LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, |
||||
| 3340 | 25146874 |
US |
66 | 1 |
Cerebral haemorrhage, Hypertensive emergency, Epistaxis, Headache, Brain fog, Fatigue, Pain in extremity, Paraesthesia, Burning sensation, Hypertension, Product packaging difficult to open, Nausea, Dizziness, Confusional state, |
||||
LENVATINIB, LENVATINIB, LENVATINIB, LOSARTAN, LOSARTAN, LORAZEPAM, |
||||
| 3341 | 25146922 |
GB |
31 | 2 |
Pallor, Myalgia, Tachycardia, Nausea, Chest discomfort, Dizziness, Pruritus, Paraesthesia, |
||||
| 3342 | 25147344 |
GB |
63 | 2 |
Malaise, Hypoaesthesia, Paraesthesia, Headache, |
||||
EZETIMIBE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, EMPAGLIFLOZIN, LOSARTAN, TIRZEPATIDE, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), |
||||
| 3343 | 25139025 |
US |
31 | 1 |
Pain, Hypoaesthesia, Cyanosis, Tetany, Paraesthesia, Muscle spasms, |
||||
TRISODIUM CITRATE DIHYDRATE, GABAPENTIN, TESTOSTERONE, TESTOSTERONE,, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, TIZANIDINE, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, |
||||
| 3344 | 25139335 |
US |
59 | 1 |
Rheumatoid arthritis, Paraesthesia, Hypoaesthesia, Condition aggravated, Insomnia, |
||||
SARILUMAB, |
||||
| 3345 | 25139603 |
FI |
2 | |
Seizure, Product odour abnormal, Chills, Hypoaesthesia, Blood pressure increased, Paraesthesia, Skin burning sensation, Anxiety, Discomfort, |
||||
ROSUVASTATIN, |
||||
| 3346 | 25139790 |
CA |
71 | 1 |
Hypertension, Sleep apnoea syndrome, Nausea, Pruritus, Dry mouth, Ageusia, Rash erythematous, Dry skin, Pain, Dry eye, Alopecia, Heart rate decreased, Mucosal inflammation, Rash, Fatigue, Cognitive disorder, Paraesthesia, Flushing, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, PANTOPRAZOLE, |
||||
| 3347 | 25140042 |
US |
58 | 1 |
Back disorder, Abdominal pain, Paraesthesia, Hypoaesthesia, |
||||
POMALIDOMIDE, ACYCLOVIR, LORAZEPAM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, GABAPENTIN, POTASSIUM CHLORIDE, MORPHINE SULFATE, ERGOCALCIFEROL, MELATONIN, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, POTASSIUM CHLORIDE, |
||||
| 3348 | 25140063 |
IT |
68 | 2 |
Hypokalaemia, Paraesthesia, Asthenia, Anaemia, |
||||
OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, BEVACIZUMAB, |
||||
| 3349 | 25140159 |
US |
73 | 2 |
Gait disturbance, Arthralgia, Paraesthesia, Burning sensation, |
||||
AVACOPAN, PREDNISONE, PREDNISONE, EZETIMIBE, DAPAGLIFLOZIN, LACOSAMIDE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, PITAVASTATIN CALCIUM, CALCIUM, FISH OIL, |
||||
| 3350 | 25140673 |
US |
63 | 2 |
Paraesthesia, |
||||
DULAGLUTIDE, |
||||
| 3351 | 25141026 |
US |
||
Illness, Fatigue, Muscle tightness, Paraesthesia, |
||||
UBLITUXIMAB, UBLITUXIMAB, |
||||
| 3352 | 25141267 |
CO |
13 | 1 |
Paraesthesia, Hypocalcaemia, Hypoaesthesia, |
||||
CYSTEAMINE BITARTRATE, CYSTEAMINE HYDROCHLORIDE, ASCORBIC ACID, ERYTHROPOIETIN, ENALAPRIL, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, FOLIC ACID, LEVOTHYROXINE, POTASSIUM CITRATE, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, |
||||
| 3353 | 25141552 |
US |
76 | 2 |
Gastrointestinal disorder, Diarrhoea, Diastolic hypotension, Hospitalisation, Ascites, Flatulence, Dysgeusia, Decreased appetite, Dyspnoea, Headache, Weight decreased, Dizziness, Fatigue, Abdominal distension, Asthenia, Hypoaesthesia, Paraesthesia, Pain in extremity, |
||||
RIOCIGUAT, RIOCIGUAT, TREPROSTINIL, FUROSEMIDE, ACETAMINOPHEN, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, FOLIC ACID, TEMAZEPAM, PYRIDOXINE HYDROCHLORIDE, ERGOCALCIFEROL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SPIRONOLACTONE, OXYGEN, 0XYGEN, AMBRISENTAN, SOTATERCEPT-CSRK, |
||||
| 3354 | 25141788 |
US |
2 | |
Hypoaesthesia, Paraesthesia, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 3355 | 25142046 |
IT |
68 | 2 |
Hypokalaemia, Paraesthesia, Anaemia, Asthenia, |
||||
FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, BEVACIZUMAB, OXALIPLATIN, |
||||
| 3356 | 25142196 |
US |
33 | 2 |
Throat tightness, Paraesthesia, Headache, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 3357 | 25142225 |
US |
1 | |
Fall, Spinal fracture, Paraesthesia, Pain in extremity, Neck surgery, Influenza, Asthenia, Product use issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 3358 | 25142290 |
CA |
45 | 1 |
Swelling face, Erythema, Dizziness, Paraesthesia, Feeling hot, |
||||
TESTOSTERONE, TESTOSTERONE, TESTOSTERONE,, BUDESONIDE, DUPILUMAB, DUPILUMAB, |
||||
| 3359 | 25142413 |
US |
41 | 2 |
Paraesthesia, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 3360 | 25142433 |
US |
1 | |
Paraesthesia, Pain, Agitation, Muscle spasms, Adverse event, Therapy cessation, Fatigue, Irritability, Muscle spasms, Condition aggravated, Loss of personal independence in daily activities, |
||||
RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 3361 | 25142465 |
US |
54 | 2 |
Eyelid irritation, Paraesthesia, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 3362 | 25142565 |
US |
2 | |
Hallucination, Hip fracture, Paraesthesia, Bone pain, Dizziness, Loss of personal independence in daily activities, |
||||
ABALOPARATIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), HYDROCODONE BITARTRATE AND ACETAMINOPHEN, |
||||
| 3363 | 25142866 |
US |
2 | |
Paraesthesia, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 3364 | 25142878 |
US |
2 | |
Anxiety, Decreased appetite, Back pain, Paraesthesia, Blood pressure fluctuation, Retching, Illness, Product lot number issue, Product substitution issue, Tremor, Therapeutic response decreased, Fatigue, Mental impairment, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 3365 | 25144830 |
91 | 2 | |
Asthenia, Malaise, Hypoaesthesia, Paraesthesia, Decreased appetite, Vomiting, Nausea, Hypoaesthesia, |
||||
DENOSUMAB, |
||||
| 3366 | 25138703 |
GB |
30 | 2 |
Paraesthesia, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 3367 | 25137430 |
ES |
65 | 2 |
Hypertensive crisis, Paraesthesia, Dizziness, Gait disturbance, |
||||
RISANKIZUMAB-RZAA, |
||||
| 3368 | 25137902 |
PL |
50 | 2 |
Vision blurred, Dyspnoea, Paraesthesia, Nausea, Ear discomfort, Asthenia, Speech disorder, Off label use, |
||||
BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, |
||||
| 3369 | 25141429 |
41 | 2 | |
Flushing, Tinnitus, Anxiety, Palpitations, Dyspnoea, Confusional state, Disorientation, Anal incontinence, Urinary incontinence, Vomiting, Hypoaesthesia, Paraesthesia, Neck pain, Chills, Dystonia, |
||||
GLATIRAMER ACETATE, |
||||
| 3370 | 25132062 |
US |
1 | |
Feeling abnormal, Myalgia, Pain in extremity, Muscle strain, Fatigue, Dizziness, Central nervous system lesion, Somnolence, Paraesthesia, Gait disturbance, Hypoaesthesia, Hyperhidrosis, Product temperature excursion issue, Inappropriate schedule of product administration, Product dose omission in error, Vision blurred, |
||||
OFATUMUMAB, OFATUMUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, PREDNISOLONE SODIUM PHOSPHATE, |
||||
| 3371 | 25132283 |
US |
39 | 1 |
Hallucination, visual, Paraesthesia, Hypoaesthesia, Post-traumatic stress disorder, Obsessive-compulsive disorder, Dissociation, Panic attack, Fear, Abnormal behaviour, |
||||
ESKETAMINE HYDROCHLORIDE, |
||||
| 3372 | 25132325 |
US |
73 | 1 |
Musculoskeletal stiffness, Pain, Hypoaesthesia, Paraesthesia, |
||||
DUPILUMAB, |
||||
| 3373 | 25132363 |
US |
||
Loss of consciousness, Paraesthesia, |
||||
HYDROCHLOROTHIAZIDE, |
||||
| 3374 | 25132557 |
US |
50 | 2 |
Paraesthesia, |
||||
AVAPRITINIB, AVAPRITINIB, |
||||
| 3375 | 25132676 |
CA |
2 | |
Neuropathy peripheral, Nasopharyngitis, Dysphagia, Dizziness, Insomnia, Visual impairment, Hypoaesthesia, Paraesthesia, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 3376 | 25133105 |
CA |
57 | 1 |
Blood creatinine increased, End stage renal disease, Neuropathy peripheral, Proteinuria, Hypoaesthesia, Paraesthesia, Viraemia, Viruria, |
||||
BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MYCOPHENOLIC ACID, PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, APIXABAN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, DAPAGLIFLOZIN, INSULIN HUMAN, MAGNESIUM CARBONATE, |
||||
| 3377 | 25133551 |
CA |
||
White blood cell count increased, Rheumatic fever, X-ray abnormal, Lung disorder, Laryngitis, Grip strength, Pneumonia, Visual impairment, Stomatitis, Weight increased, Joint range of motion decreased, Bone erosion, Irritable bowel syndrome, Lupus-like syndrome, Systemic lupus erythematosus, Muscle injury, Impaired healing, Dyspnoea, Hepatic enzyme increased, Abdominal pain upper, Headache, Oedema, Loss of personal independence in daily activities, Dizziness, Night sweats, Weight fluctuation, Swollen joint count increased, Pancreatitis, Rectal haemorrhage, Rheumatoid arthritis, Decreased appetite, Obesity, Laboratory test abnormal, Weight decreased, Diarrhoea, Gait disturbance, Glossodynia, Hand deformity, Exostosis, Mobility decreased, Liver disorder, Musculoskeletal stiffness, Sciatica, General physical health deterioration, Adjustment disorder with depressed mood, Depression, Arthritis, Facet joint syndrome, Insomnia, Lip dry, Vomiting, Discomfort, Hepatic cirrhosis, Folliculitis, Inflammation, Pyrexia, Liver injury, Autoimmune disorder, Anti-cyclic citrullinated peptide antibody positive, Peripheral swelling, Oedema peripheral, Pain, Fibromyalgia, Wound, Hypoaesthesia, Condition aggravated, Gastrointestinal disorder, Nasopharyngitis, Feeling hot, Memory impairment, Delirium, Swollen joint count, Breast cancer stage III, Asthma, Porphyria acute, Paraesthesia, Foot deformity, Wheezing, Synovitis, Ill-defined disorder, Arthralgia, Dry mouth, Crohn^s disease, Muscle spasms, Muscular weakness, Rash, Chest pain, Contusion, Infusion related reaction, Peripheral venous disease, Rheumatoid factor positive, Duodenal ulcer perforation, Migraine, Abdominal discomfort, Hypertension, Osteoarthritis, Sinusitis, Pruritus, Grip strength decreased, Asthenia, Type 2 diabetes mellitus, Fatigue, Musculoskeletal pain, Sleep disorder due to general medical condition, insomnia type, Pemphigus, Sleep disorder due to a general medical condition, Abdominal pain, Pulmonary fibrosis, C-reactive protein abnormal, Blood cholesterol increased, Hypersensitivity, Nausea, Joint swelling, Arthropathy, Swelling, Blister, Walking aid user, Drug hypersensitivity, Amnesia, Retinitis, Bursitis, Osteoporosis, Anxiety, Dyspepsia, Frequent bowel movements, Urticaria, Hypercholesterolaemia, Injury, Colitis ulcerative, Psoriatic arthropathy, Malaise, Lupus vulgaris, Confusional state, Dislocation of vertebra, Road traffic accident, Alopecia, Pericarditis, Infection, Ear infection, Lower respiratory tract infection, Wound infection, Helicobacter infection, Maternal exposure during pregnancy, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, SECUKINUMAB, SECUKINUMAB, RAMIPRIL, LISINOPRIL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ERYTHROMYCIN, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, HYDROXYCHLOROQUINE SULFATE, LANSOPRAZOLE, ERGOCALCIFEROL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, TOCILIZUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, APREMILAST, APREMILAST, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, PREGABALIN, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PREGABALIN, HYALURONIDASE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, LEFLUNOMIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DESOXIMETASONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LORAZEPAM, FLUOROMETHOLONE, SULFASALAZINE, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, MESALAMINE, TOFACITINIB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LISINOPRIL, RITUXIMAB, RITUXIMAB, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, CAFFEINE, MELOXICAM, MORPHINE, MAGNESIUM, USTEKINUMAB, TOFACITINIB, TOFACITINIB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, LANSOPRAZOLE, INFLIXIMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, CALCIUM CARBONATE, ANTACID, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, SECUKINUMAB, |
||||
| 3378 | 25133921 |
US |
61 | 1 |
Paraesthesia, |
||||
DUPILUMAB, |
||||
| 3379 | 25133999 |
US |
2 | |
Viral pericarditis, Blepharitis, Emergency care examination, Paraesthesia, Dyspnoea, Arthralgia, Chest pain, Anaemia, Hepatic enzyme increased, Peripheral swelling, Constipation, |
||||
RUCAPARIB, RUCAPARIB, COLCHICINE, MAGNESIUM, |
||||
| 3380 | 25134100 |
US |
44 | 1 |
Dry skin, Paraesthesia, Pruritus, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3381 | 25134109 |
DE |
||
Paraesthesia, Muscle spasms, Hypoaesthesia, |
||||
| 3382 | 25134113 |
US |
2 | |
Autoimmune pancreatitis, Cushingoid, Muscular weakness, Paraesthesia, Fatigue, Colitis ulcerative, Steroid dependence, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, PREDNISONE, PREDNISONE, |
||||
| 3383 | 25134300 |
FI |
74 | 2 |
Seizure, Exposure via partner, Accidental exposure to product, Chills, Paraesthesia, Hypoaesthesia, Blood pressure increased, |
||||
| 3384 | 25134378 |
US |
51 | 2 |
Limb discomfort, Pain in extremity, Paraesthesia, |
||||
DUPILUMAB, |
||||
| 3385 | 25134540 |
US |
66 | 2 |
Blood glucose increased, Back pain, Trigger finger, Arthralgia, Fall, Pain in extremity, Muscle spasms, Hypoaesthesia, Paraesthesia, Blood potassium decreased, Blood glucose fluctuation, Malaise, Pain, Mobility decreased, Atrophy, Lipodystrophy acquired, Infusion site bruising, Infusion site haemorrhage, |
||||
INSULIN LISPRO-AABC, INSULIN LISPRO-AABC, INSULIN LISPRO-AABC, INSULIN GLARGINE, |
||||
| 3386 | 25135068 |
US |
2 | |
Paraesthesia, Peripheral coldness, |
||||
RIMEGEPANT SULFATE, |
||||
| 3387 | 25135174 |
US |
65 | 1 |
Neuropathy peripheral, Mental impairment, Neuropathy peripheral, Pancreatic atrophy, Device related infection, Product dose omission issue, Catheter site infection, Fatigue, Abdominal discomfort, Weight decreased, Paraesthesia, Oral pain, Oropharyngeal pain, Chills, Tremor, Asthenia, Taste disorder, Paraesthesia oral, Brain fog, Tendonitis, Taste disorder, Abnormal faeces, Glossodynia, |
||||
IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE, OXALIPLATIN, |
||||
| 3388 | 25135376 |
GB |
||
Back pain, Somnolence, Fatigue, Pain in extremity, Paraesthesia, Hypoaesthesia, Drug hypersensitivity, |
||||
INFLIXIMAB-DYYB, |
||||
| 3389 | 25135606 |
CA |
21 | 2 |
Mast cell activation syndrome, Postural orthostatic tachycardia syndrome, Influenza like illness, Laboratory test abnormal, Respiratory symptom, Dysuria, Condition aggravated, Paraesthesia, Pollakiuria, Ehlers-Danlos syndrome, Food intolerance, Fatigue, Migraine, Pain, |
||||
EPTINEZUMAB-JJMR, EPTINEZUMAB-JJMR, TOPIRAMATE, MEMANTINE, MEMANTINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, RANITIDINE, |
||||
| 3390 | 25135790 |
US |
29 | 1 |
Neuropathy peripheral, Weight increased, Fatigue, Periorbital swelling, Arthralgia, Joint lock, Hypersomnia, Emotional disorder, Dysphemia, Peripheral swelling, Dizziness, Dyspnoea, Paraesthesia, Grip strength decreased, Blepharospasm, Muscular weakness, Chest pain, Drooling, Muscle twitching, Blood lactic acid increased, |
||||
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE, |
||||
| 3391 | 25135821 |
AU |
28 | 2 |
Maternal exposure during pregnancy, Hypotension, Paraesthesia, |
||||
| 3392 | 25135937 |
US |
||
Death, Sudden death, Embolism, Rectal haemorrhage, Thrombocytopenia, Haemorrhage, Paraesthesia, Dyspepsia, Fatigue, Influenza like illness, Dizziness, Hypoaesthesia, |
||||
ROMIPLOSTIM, AVATROMBOPAG, |
||||
| 3393 | 25135941 |
US |
2 | |
Drug ineffective, Paraesthesia, Dysarthria, Dysarthria, Blepharospasm, Hypoaesthesia, |
||||
OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, ATROPINE SULFATE, ATROPINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, LORAZEPAM, METHYLPREDNISOLONE, FAMOTIDINE, LORAZEPAM, HYDROCORTISONE ACETATE, |
||||
| 3394 | 25136048 |
US |
78 | 1 |
Knee arthroplasty, Colitis ulcerative, Paraesthesia, Product dose omission issue, Device issue, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 3395 | 25136550 |
BE |
2 | |
Paralysis, Paraesthesia, Off label use, |
||||
ORAL SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 3396 | 25136726 |
CA |
76 | 1 |
Dizziness, Erythema, Immunisation reaction, Influenza, Malaise, Nasopharyngitis, Oedema peripheral, Paraesthesia, Syncope, Balance disorder, Fall, Leukaemia, Myasthenia gravis, Drug ineffective for unapproved indication, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 3397 | 25136839 |
US |
||
Nausea, Paraesthesia, Hypoaesthesia, |
||||
SUZETRIGINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 3398 | 25136871 |
US |
81 | 1 |
Loss of consciousness, Malaise, Hypoaesthesia, Paraesthesia, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 3399 | 25126559 |
CA |
||
Amnesia, Adjustment disorder with depressed mood, Anxiety, Asthenia, Blood cholesterol increased, Breast cancer stage II, Decreased appetite, Delirium, Depression, Dislocation of vertebra, Dry mouth, Dyspepsia, Facet joint syndrome, Fibromyalgia, Gait disturbance, General physical health deterioration, Grip strength decreased, Headache, Hypertension, Hypoaesthesia, Ill-defined disorder, Inflammation, Injury, Lip dry, Liver disorder, Liver injury, Lung disorder, Malaise, Memory impairment, Migraine, Muscle spasms, Muscular weakness, Musculoskeletal pain, Night sweats, Obesity, Osteoarthritis, Paraesthesia, Peripheral venous disease, Psoriatic arthropathy, Rheumatic fever, Sciatica, Sleep disorder, Swollen joint count increased, Type 2 diabetes mellitus, Weight decreased, X-ray abnormal, Lupus vulgaris, Wound infection, Medication error, Product use issue, Intentional product use issue, Prescribed overdose, Product use in unapproved indication, Off label use, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, |
||||
| 3400 | 25126649 |
CA |
||
Crohn^s disease, Dizziness, Paraesthesia, Product use in unapproved indication, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30
